Our unwavering focus
Ascendis Pharma is a global biopharmaceutical company committed to making a meaningful difference in patients’ lives. Guided by our core values of Patients, Science, and Passion, we apply our innovative TransCon® technology platform to develop new therapies that demonstrate best-in-class potential to improve treatment safety, efficacy, tolerability, and convenience.
With headquarters in Denmark, research facilities in Germany, and offices across Europe and the United States, we are advancing programs in Endocrinology Rare Disease and Oncology. In addition, we collaborate with partners around the world on the development of TransCon-based products in other therapeutic areas and markets.